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Abstract
Tumor progression: In many (perhaps in all) tumor systems, a malignant cancer is preceded by
a benign lesion. Most benign lesions do not transform to malignancy and many regress. The final
transformative step to malignancy differs from the preceding steps in, among other things, that it
often occurs in the absence of the original carcinogenic stimulus.
Mechanism of immunostimulation: Relatively low titers of specific immune reactants are
known to stimulate, but cell-to-cell or cell-to-matrix interactions appear to be major inhibitors of
tumor-growth. Therefore, it seems reasonable to hypothesize that the mechanism of
immunostimulation may be an interference with cell-to-cell or cell-to-matrix communication by a
sub-lethal immune-reaction.
Discussion: While the above hypothesis remains unproven, some evidence suggests that immunity
may have a major facilitating effect on tumor growth especially at the time of malignant
transformation. There is even some evidence suggesting that transformation in vivo may seldom
occur in the absence of immunostimulation of the premalignant lesion. Positive selection by the
immune reaction may be the reason that tumors are immunogenic.
Tumor progression
It is widely believed that each malignant tumor is a clone
of abnormal cells. However, there is great phenotypic and
genetic diversity within the cancer-cell population owing
to an ongoing process of variation and selection. This con-
tinuing process results in "progression"; the term, as used
by Foulds [1], describes the progressive changes in the bio-
logical attributes within a lesion, including dedifferentia-
tion. The term, by definition, is not directly related to the
tumor's physical growth or extent. I will first review some
of the more notable observations that suggest that, during
the course of progression, many (all?) malignancies pass
through an earlier benign stage before they transform into
the malignant state.
Among breeding mice of the C3H/An strain, 100% of over
1500 females developed breast cancer [2]. There were
numerous HAN (benign hyperplastic alveolar nodules) in
each mammary gland as a result of the action of the MTV
(milk agent – mammary tumor virus). However, an indi-
vidual mouse seldom developed more than one carci-
noma; the transformation from benign HAN to
carcinoma was thus a rare event. The striking feature of the
data was that the percentage of surviving mice that devel-
oped a breast cancer in each successive month, from the
9th to the 14th, was virtually a constant [2]. The implica-
tion is that the benign HAN progressed to one-step-short
of malignancy and then awaited a further malignancy-
conferring event, an event that, after the 9th month, had a
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constant probability of occurring in any subsequent
monthly interval.
Breast cancer and cervical cancer in women show similar
plateaus in the incidence curves, albeit the curves tends to
rise slightly with age [2].
Lappé and Prehn studied the development of mouse skin
papillomas in response to "initiation" with 3-methylcho-
lanthrene (MCA) [3]. The method of producing the papil-
lomas was to treat the skin of a normal mouse with a sub-
carcinogenic dosage of MCA and then graft that skin onto
a syngeneic mouse whose immunologic capacity had
been raised or lowered by various techniques. The trauma
of transplantation served as a "promoter" of the "initi-
ated" skin. A seminal finding was that, in each group,
malignant transformation, as a percentage of the papil-
loma-days at risk, was a constant; ie., each papilloma,
regardless of its duration and/or presumed immunogenic-
ity, had the same probability of transformation in any
subsequent interval of time [3].
Cairns has called attention to a similar observation [4] in
the published work of Halpern et al.. Halpern reported
that the probability, per year, of death from human lung
cancer stays virtually constant for the next 10–20 years
after an individual stops smoking [5]. Apparently, the
longer one smokes the larger the number of premalignant
lesions that will be induced, but once induced, each lesion
retains a constant probability of malignant transforma-
tion in each subsequent year.
The preceding five examples suggest that most and per-
haps all potential cancers, at some point early in their evo-
lution, consist of benign lesions that very seldom progress
to malignancy. Thus, carcinogenesis is not a smooth proc-
ess of numerous tiny increments, but is usually punctu-
ated by at least one, often prolonged, period of apparent
stasis while awaiting, often in vain, for the type of altera-
tion that marks the transformation from a benign lesion
into a malignancy [4]. Of perhaps greatest significance is
the deduction that the final transformation may be of a
nature different from the preceding changes that pro-
duced the benign precursor lesion; this is evident from the
fact that in most of the five examples cited the carcinogenic
agent was almost certainly long gone at the time of the malig-
nant transformation. However, in each case the final trans-
forming step occurred with a virtually unchanged
probability over successive intervals of time.
Immunostimulation
Ever since the dawn of the twentieth century, the immune
reaction has been associated primarily with the defense
against foreign invaders, bacterial and viral. This defense
involved the killing of the invading organisms and it was
readily apparent that such a lethal defense system was
absolutely essential for our survival; if it failed, we would
be attacked and overwhelmed by the billions of micro
organisms that constantly surround us. Nothing seemed
to be more obvious than that under no circumstances
could an animal tolerate being, in whole or in part, mis-
taken by its own immune system, for a foreign invader;
"horror autotoxicus" in the words of Paul Ehrlich [6].
However, the immune reaction has been found to be
exceedingly complex and composed of many constituent
parts of which various forms of lymphoid cells seem per-
haps of greatest import. It gradually became obvious that
autoimmunity could indeed occur and that various
autoimmune diseases were all too common [6]; we do not
often succumb to such diseases because the immune sys-
tem usually learns, early in life, what it should and should
not attack.
When milder forms of autoimmunity occur, the target
cells may not be killed, but may instead undergo an exten-
sive hyperplasia. To the pathologist, this association is as
common as "bread and butter". That the immune reaction
is actually the cause of the hyperplasia is most easily illus-
trated by the analysis of a mild alloimmunity in which it
was possible to titrate the strength of the reaction. Chai
tried to develop inbred rabbits [7]. Therefore, numerous
generations of brother-sister matings were enabled. As the
animals became more inbred, reciprocal skin grafts were
performed to test the genetic identity that was gradually
approached. As the animals neared homozygosity, the
skin grafts were no longer rejected as is the case with for-
eign grafts. Instead, they underwent a chronic acanthosis
and epithelial hyperplasia. Of course, animals that are
fully inbred accept isografts with only a minor and tempo-
rary inflammatory reaction. Numerous other examples, in
which an immune reaction appears to have produced
hyperplasia in normal tissues, have been documented [8].
If we admit that an immune reaction can produce hyper-
plasia in an overtly normal target tissue, can one surround
a tumor with immune lymphoid cells and insist that they
are inhibiting tumor growth?
The fact that an immune reaction may, under some cir-
cumstances, act to enhance rather than inhibit neoplastic
growth has been known for many years [9]. The first con-
vincing demonstration that more might be involved than
a mere blockage of a defensive aspect of immunity was
probably a study with 3-methylcholanthrene (MCA)-
induced mouse sarcomas in a totally syngeneic system
[10]. A fixed number of sarcoma cells was mixed with var-
ied numbers of immune spleen cells, ie., spleen cells from
mice that had previously grown the same tumor. The
resulting tumor growths, when such an admixture was
implanted subcutaneously in radiated and thymect-Theoretical Biology and Medical Modelling 2007, 4:16 http://www.tbiomed.com/content/4/1/16
Page 3 of 6
(page number not for citation purposes)
omized hosts, were compared with controls consisting of
that same tumor mixed with nonimmune spleen cells or
with no spleen cells. It was found that relatively small
numbers of admixed immune cells stimulated tumor growth
while larger numbers of the same cells were inhibitory (figure
1 – the immune-reaction-curve or IRC). The fact that the
host animals had been radiated and thymectomized sug-
gested that a blockage of host immunity was an unlikely
explanation for the apparently stimulated growth. In sub-
sequent years, a large literature has appeared suggesting
that the immunostimulation phenomenon may be exhib-
ited by a variety of tumor systems and by a variety of
immune reactants, such as antiserum, macrophages, NK
cells, cytotoxic lymphoid cells, etc. acting either separately
or in algebraic aggregate [11-13]. At this time, I tentatively
venture the hypothesis that any entity capable of binding
an antigen on a neoplastic cell can probably exhibit the
same phenomenon; ie., stimulation of the target cells at
low titer, but tumor-inhibition or killing at high.
While this discussion has emphasized the role of the shear
quantity of immune reactants, the immune response has
many component parts and is very complicated; the qual-
ity of the reactants at the antigenic site is also influential
[14]. (See Outzen's review of older literature [13]).
Analysis of the effect of immunodepression of the recipi-
ent mice, in the previously discussed Lappé/Prehn papil-
loma study, showed that a moderate immunodepression
increased papilloma-incidence, papilloma-progression to
malignancy, and delayed papilloma-regression [3], a
result consistent with either increased immunostimula-
tion or decreased immunoinhibition of the papillomas
depending upon whether the reaction's location was to
the left or to the right respectfully of point "e" on the
immune -reaction-curve [15] (Figure 1); in either case, the
reaction would be to the right of "c". The important point
for the immediate discussion is that the immune reaction
definitely influenced the growth of both premalignant
and malignant lesions.
By contrast, the incidence of rectal carcinoma has been
reported to be dramatically less in immunodepressed kid-
ney-transplant patients [16]. Such a phenomenon, if
caused by the immunosuppression, would place the
lesion to the left of "c" on the IRC (figure 1). This is the
only region on the IRC where a reduced immune-reaction
would result in less tumor growth. However, there is over-
whelming evidence, from surgical specimens of malig-
nant  colorectal-lesions, that a heavier immune-cell
infiltrate is associated with an improved prognosis [17].
This observation would place the reaction somewhere on
The immune response curve (IRC), idealized from data in [10] Figure 1
The immune response curve (IRC), idealized from data in [10]. The lettered and numbered points are inserted only to aid the 
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the slope to the right of "c". These two somewhat different
results can be reconciled since it is apparently only the rec-
tal carcinomas whose incidence is decreased by immuno-
depression; when colonic lesions are considered together
with the rectal lesions, the average positon on the IRC is
shifted, as would be expected, to the right.
Immunostimulation of malignant 
transformation
As shown with the MCA-induced skin papillomas [3],
immunity probably acts throughout the life of a tumor
and is not limited to the period of malignant transforma-
tion. However, a reinvestigation of the skin-papilloma
system, with a slightly modified protocol, gave added
insight [18]. Andrews' methodology was to expose mouse
skin to the MCA before transplantation to an allogeneic
rather than to a syngeneic host. In order to permit the
grafts to survive in the allogeneic host, the host animals
were maximally immunodepressed by thymectomy, x-
radiation and weekly injections of antithymocyte serum.
No evidence of surviving immune function could be
found, so the reaction was presumably near "a" on the
IRC. Nonetheless, about 80% of the induced papillomas
regressed and, most surprisingly, none progressed to malig-
nancy. Apparently an immune reaction was necessary, in
this system, for malignant transformation (See discussion
in [12]).
The Andrew's experiment was unique in its extreme
degree of immunodepression [18]. An abundance of stud-
ies in mice with varied immune capacities show that the
degree of immunodepression is critical for carcinogenesis
and tumor growth. However, the titrations were not car-
ried to the extreme used by Andrews, but covered the
range in which an intermediate level of immune capacity
was associated with maximal tumor growth while either
less or more capacity produced relatively less growth [19].
In experiments patterned upon the methodology used by
Lappé and Prehn, skin tumor production in germ-free
nude mice was consistantly less than in immunologically
reconstituted nudes [13]. However, implants of highly
immunogenic, and only of highly immunogenic, tumors
grew better in irradiated than in non-irradiated nudes
[20]. These observations suggest that the reactions to the
tumors in the nudes fell somewhere to the left of "c" but,
in contrast to the work of Andrews, well to the right of "a"
on the IRC (Figure 1).
The transformation of benign nevi into melanomas also
suggests a critical role for immunity. Most cutaneous
malignant-melanomas probably arise in preexisting
benign-nevi (albeit many of the nevi may be too small to
be grossly detected so this relationship is not secure). The
incidence of benign-nevi is increased dramatically in peo-
ple who are immunodepressed to make kidney-allografts
possible [21]. Nevi are also more numerous in patients
suffering from AIDS which suggests that it is indeed
immunosuppression  per se that is responsible for the
increase [21]. I argue that it is probably not lack of immu-
nosurveillance that accounts for the increased incidence
of nevi in immunodepressed patients; there is little or no
immune-cell infiltrate associated with nevi in immunon-
ormal individuals. It seems more likely that immunode-
pression weakens an already weak immunity and, by so
doing, moves the reaction along the curve in figure 1 from
near "d" or "e" toward "c", thus increasing the level of
tumor-stimulation and so increasing the number and size
of nevi. While I feel it to be unlikely, a not mutually-exclu-
sive explanation cannot be dismissed; namely, that since
melanocytes can serve as antigen presenting cells [22], the
excess of nevi in immunodepressed patients might be the
result of a compensatory hyperplasia.
Although an immune reaction may play a stimulatory role
in the life of a nevus, at the time of transformation of a
nevus into a malignant melanoma, the immune response
is markedly increased as judged by the often heavy
immune-cell infiltrate. Whether it increases sufficiently to
actually become inhibitory is not clear; it has been
claimed that the heavier the infiltrate in the mature lesion,
the better the prognosis [23]. This observation, if substan-
tiated, would be consistent with the heavier infiltrate
being either less stimulatory or being more inhibitory (it
would be somewhere on the slope to the right of "c" on
the IRC).
The significant point for the immediate discussion is that
the heavier immune-cell infiltrate, in conjunction with
the transformation of a nevus into a malignant
melanoma, suggests an amplified role for immunity dur-
ing the process of transformation per se.
Societal control of malignancy
The well-established fact that cancer is often held in check
by interaction with matrix or with neighboring cells has
been well reviewed, most recently by Bissell et al [24] and
by Rubin [25]. In fact, the cancer phenotype can some-
times be normalized in vivo by forced contact of the cancer
cells with surrounding parental normal cells. Suitable
markers, as well as recovery of the original cancer pheno-
type, testify to the fact that a phenotypic change from can-
cer to normal and back again did actually occur in a
tumor-cell lineage [25,26].
Interference with gap-junctional-communication may
play a part in the societal control of tumor growth [27],
but is apparently not always necessary [25]. In fact, in the
case of the hyperplastic nodules of the mouse breast, a
nodule implanted into a gland-containing fat-pad is
inhibited by the presence of the normal glandular-tissueTheoretical Biology and Medical Modelling 2007, 4:16 http://www.tbiomed.com/content/4/1/16
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without the necessity of direct contact [28]. By contrast, an
implant of overt carcinoma is not inhibited by the pres-
ence of normal gland [29]. Thus, as might be expected, it
seems that there are probably a variety of mechanisms by
which the normal cellular society tends to keep deviant
cells under control, but these controls lose effect as the
deviants become progressively less normal and as the soci-
etal controls diminish with the aging of the individual
[25].
Mechanism of immunostimulation
Inasmuch as immunity can be a tumor-stimulator, but
cell-to-cell or cell-to-matrix interactions appear to be
major inhibitors [24-26], it seems reasonable to suggest
that the mechanism of immunostimulation may be an
interference with cell-to-cell or cell-to-matrix communica-
tion by a sub-lethal  immune-reaction. Immunity is
dependent upon interactions with cell-surface antigens
and so would appear to be a logical mechanism for inter-
fering with such communications. However, direct evi-
dence in support of this hypothesis is not presently
available.
Discussion
The hypothesis that immunostimulation of tumor growth
may result from interference with cell-to-cell communica-
tions seems likely, but remains unproven; the idea that
immunostimulation is peculiarly effective during trans-
formation from benign to malignant is even more tenu-
ous. Melanoma is the only tumor system, of which I am
aware, in which there is seemingly clear evidence of a pro-
found change in the immune infiltrate at the time of trans-
formation to malignancy. The phenomenon may be
universal, but evidence from other systems does not
appear, at present, to be available.
However, a role for immunity in malignant transforma-
tion per se is also suggested by the failure, already dis-
cussed, of mouse skin-papillomas to undergo
transformation if the host's immune-capacity is not only
diminished, but virtually abolished [18] (see discussion
in [12]). This observation suggests, quite independently
of observations of immune-cell-infiltrations, that immu-
nity may specifically facilitate rather than inhibit malig-
nant-transformation and may even be necessary for such
transformation in vivo. At present this idea remains an
attractive hypothesis. If it were correct, one would be faced
with envisioning some plausible mechanism for the pos-
tulated increased blockage of intercellular communica-
tion at the time of transformation.
The final step in the transformation process might be a
new mutation or some epigenetic alteration that, in the
context of the benign lesion, would occur with an
unchanging probability over time and that would increase
the effective immunogenicity of the tumor.
Cairn's "immortal strand" might, if that thesis were cor-
rect, provide one possible explanation [4]. He proposes
that the final step in transformation may occur when the
postulated immortal chromatid strand, preserved in a
stem-cell, is effectively replaced when the stem cell itself is
replaced by a newly dedifferentiated daughter-cell; the
daughter cell is postulated to be more capable of symmet-
rical division, ie., the old stem-cell is superseded by a new
defective-stem-cell that is less subject to the societal inhi-
bitions that usually prevent symmetrical division of stem-
cells [4]. The new, replacement stem-cell might carry accu-
mulated antigenic mutations not present in the super-
seded immortal strand and thus provide, concurrently
with malignant transformation, greater antigenic stimula-
tion; this in turn might provide increased stimulation of
tumor growth if the reaction were to the left of "c" on the
IRC (Figure 1).
If the immune reaction is indeed a necessary adjunct to
malignant transformation, the lower incidence of some
cancers, such as rectal [16] and breast [30], in immunode-
pressed patients is probably explained by the movement
of the reaction further to the left of "c" on the IRC. How-
ever, the incidences of most other tumors are probably
mildly elevated in immunodepressed patients [16] and
some, such as skin cancers and lymphoreticular tumors,
markedly so. This seeming paradox is easily explained by
the fact that various types of tumors carry differing immu-
nogenicities; the MCA-induced skin papillomas of the
mouse are relatively immunogenic and their incidence is
increased by moderate immunodepression. If a tumor's
immunogenicity places it to the right of "c" on the IRC,
immunodepression will result in a higher incidence; to
the left of "c", immunodepression will result in a lower
incidence. In general, most viral or chemically induced
tumors will be more immunogenic and tend to fall to the
right while so-called spontaneous tumors will tend to fall
to the left of "c". Unfortunately, the immunogenicities of
most human tumors can presently be judged only by the
effect of immunodepression on their incidences.
If the above argument is correct, the bottom line would
appear to be that tumors that fall to the left of "c", such as
rectal carcinomas and mammary carcinomas will proba-
bly be relatively difficult to treat by immune enhancing
measures such as vaccines (these tumors might actually be
stimulated by an effective vaccine), while skin tumors and
lymphomas, being usually to the right of "c", may be bet-
ter candidates for vaccine therapies. Furthermore, in keep-
ing with the ideas I have been forwarding, it may not be
too big a stretch to suggest that the reason tumors have
antigens is so that they can become tumors; without anti-Publish with BioMed Central    and   every 
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gens and the resulting immunostimulation, they might
never begin to grow!
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threne
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